会員登録
ログイン
【4360】マナック・ケミカル・パートナーズ
各種化学工業薬品及び医薬品の製造並びに販売や、動物用医薬品の製造及び 販売等の事業を営むグループ会社等の経営管理及びそれに付帯又は関連する 業務
類似企業：
【業界1位】
三菱ケミカルグループ
【業界1位】
三菱ケミカルグループ
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026.03 | 2026/05/14 | 実 | 10,993 | ↑ | +2.7% | +6.2% | 739 | ↑ | +23.2% | +146.3% | 825 | ↑ | +26.9% | +129.2% | 781 | ↑ | +30.2% | +212.4% |
| 2026.03 | 2026/02/13 | Q3予 | 10,700 | ↑ | +3.4% | +3.4% | 600 | ↑ | +100.0% | +100.0% | 650 | ↑ | +80.6% | +80.6% | 600 | ↑ | +140.0% | +140.0% |
| 2026.03 | 2025/11/14 | Q2予 | 10,350 | → | 0.0% | 0.0% | 300 | → | 0.0% | 0.0% | 360 | → | 0.0% | 0.0% | 250 | → | 0.0% | 0.0% |
| 2026.03 | 2025/08/08 | Q1予 | 10,350 | → | 0.0% | 0.0% | 300 | → | 0.0% | 0.0% | 360 | → | 0.0% | 0.0% | 250 | → | 0.0% | 0.0% |
| 2026.03 | 2025/05/30 | 当初予 | 10,350 | - | - | - | 300 | - | - | - | 360 | - | - | - | 250 | - | - | - |
| 2025.03 | 2025/05/14 | 実 | 9,304 | ↓ | -2.0% | -18.3% | -342 | ↓ | -90.0% | -280.0% | -275 | ↓ | -129.2% | -194.8% | -895 | ↓ | -1178.6% | -526.2% |
| 2025.03 | 2025/02/13 | Q3予 | 9,490 | ↓ | -16.7% | -16.7% | -180 | ↓ | -194.7% | -194.7% | -120 | ↓ | -141.4% | -141.4% | -70 | ↓ | -133.3% | -133.3% |
| 2025.03 | 2024/11/13 | Q2予 | 11,390 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% | 290 | → | 0.0% | 0.0% | 210 | → | 0.0% | 0.0% |
| 2025.03 | 2024/08/09 | Q1予 | 11,390 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% | 290 | → | 0.0% | 0.0% | 210 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/10 | 当初予 | 11,390 | - | - | - | 190 | - | - | - | 290 | - | - | - | 210 | - | - | - |
| 2024.03 | 2024/05/10 | 実 | 9,686 | ↑ | +0.1% | -31.8% | -106 | ↓ | -51.4% | -115.6% | -11 | ↓ | -210.0% | -101.5% | 76 | ↑ | +38.2% | -85.7% |
| 2024.03 | 2024/03/29 | 修正予 | 9,680 | ↓ | -6.0% | -31.8% | -70 | ↓ | -75.0% | -110.3% | 10 | ↓ | -75.0% | -98.7% | 55 | ↓ | -8.3% | -89.6% |
| 2024.03 | 2024/02/14 | Q3予 | 10,300 | → | 0.0% | -27.5% | -40 | → | 0.0% | -105.9% | 40 | → | 0.0% | -94.7% | 60 | → | 0.0% | -88.7% |
| 2024.03 | 2023/11/27 | 修正予 | 10,300 | ↓ | -27.5% | -27.5% | -40 | ↓ | -105.9% | -105.9% | 40 | ↓ | -94.7% | -94.7% | 60 | ↓ | -88.7% | -88.7% |
| 2024.03 | 2023/11/10 | Q2予 | 14,200 | → | 0.0% | 0.0% | 680 | → | 0.0% | 0.0% | 750 | → | 0.0% | 0.0% | 530 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/09 | Q1予 | 14,200 | → | 0.0% | 0.0% | 680 | → | 0.0% | 0.0% | 750 | → | 0.0% | 0.0% | 530 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/12 | 当初予 | 14,200 | - | - | - | 680 | - | - | - | 750 | - | - | - | 530 | - | - | - |
| 2023.03 | 2023/05/12 | 実 | 11,853 | ↓ | -1.8% | +1.3% | 991 | ↓ | -1.9% | +41.6% | 1,179 | ↓ | -0.9% | +49.2% | 821 | ↓ | -13.6% | +49.3% |
| 2023.03 | 2023/02/10 | Q3予 | 12,070 | ↑ | +3.2% | +3.2% | 1,010 | ↑ | +44.3% | +44.3% | 1,190 | ↑ | +50.6% | +50.6% | 950 | ↑ | +72.7% | +72.7% |
| 2023.03 | 2022/11/09 | Q2予 | 11,700 | → | 0.0% | 0.0% | 700 | → | 0.0% | 0.0% | 790 | → | 0.0% | 0.0% | 550 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/10 | Q1予 | 11,700 | → | 0.0% | 0.0% | 700 | → | 0.0% | 0.0% | 790 | → | 0.0% | 0.0% | 550 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/13 | 当初予 | 11,700 | - | - | - | 700 | - | - | - | 790 | - | - | - | 550 | - | - | - |
| 2022.03 | 2022/05/13 | 実 | 10,703 | ↑ | +4.9% | +4.9% | 740 | ↑ | +12.1% | +12.1% | 881 | ↑ | +22.4% | +22.4% | 712 | ↑ | +27.1% | +27.1% |
| 2022.03 | 2022/02/04 | Q3予 | 10,200 | → | 0.0% | 0.0% | 660 | → | 0.0% | 0.0% | 720 | → | 0.0% | 0.0% | 560 | → | 0.0% | 0.0% |
| 2022.03 | 2021/10/01 | 当初予 | 10,200 | - | - | - | 660 | - | - | - | 720 | - | - | - | 560 | - | - | - |
